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LETTER TO THE EDITOR Open Access
Prediction of long-term clinical outcomes
using simple functional exercise
performance tests in patients with COPD: a
5-year prospective cohort study
Sarah Crook1* , Anja Frei1, Gerben ter Riet2 and Milo A. Puhan1
Abstract
The 1-min sit-to-stand (1-min STS) test and handgrip strength test have been proposed as simple tests of functional
exercise performance in chronic obstructive pulmonary disease (COPD) patients. We assessed the long-term (5-year)
predictive performance of the 1-min sit-to-stand and handgrip strength tests for mortality, health-related quality of
life (HRQoL) and exacerbations in COPD patients. In 409 primary care patients, we found the 1-min STS test to be
strongly associated with long-term mortality (hazard ratio per 3 more repetitions: 0.81, 95% CI 0.65 to 0.86)
and moderately associated with long-term HRQoL. Neither test was associated with exacerbations. Our results
suggest that the 1-min STS test may be useful for assessing the health status and long-term prognosis of
COPD patients. This study was registered at http://www.clinicaltrials.gov/ (NCT00706602, 25 June 2008).
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Background
The 1-min sit-to-stand (1-min STS) test and handgrip
strength test have been proposed as simple tests of func-
tional exercise performance in chronic obstructive
pulmonary disease (COPD) patients [1, 2] that may make
assessment of functional exercise performance in practice
more accessible. Functional exercise performance is a
known predictor of clinical outcomes in COPD [3]. In a
cohort of primary care COPD patients (ICE COLD ERIC),
we have previously found functional exercise performance
measured with the 1-min STS test to be strongly associ-
ated with mortality, and both the 1-min STS and handgrip
strength tests to be moderately associated with HRQoL,
but not associated with exacerbations over 2 years of
follow-up [2]. Now that data from the complete follow-up
of the ICE COLD ERIC cohort is available, we aimed to
further investigate the predictive properties of the 1-min
STS and handgrip strength tests for long-term health
outcomes over 5 years of follow-up.
Methods
Four hundred nine COPD patients were recruited from
primary care practices in Switzerland and the
Netherlands and followed for up to 5 years. Full details
of the study design and baseline characteristics of the
cohort have been previously published [4, 5]. Patients
were assessed with the 1-min STS test and handgrip
strength test at baseline according to standardised proto-
cols [2]. The outcomes of interest were mortality (exact
dates of death retrieved from patients’ primary care
practitioners), HRQoL (biannual assessments of the
Chronic Respiratory Questionnaire (CRQ) [6]) and
exacerbations (centrally adjudicated by independent
experts using an event-based definition [7]).
We assessed the association of each test with mortality
using cox-proportional hazards models, number of exac-
erbations with negative binomial regression models and
HRQoL with multilevel linear regression models, each
with one domain of the CRQ as the outcome and a
random-intercept for time. All models were adjusted for
appropriate confounders. Models were adjusted for age,
sex, forced expiratory volume in 1 s (FEV1) L, CRQ
dyspnoea and use of LABA/ICS, except the models with
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CRQ dyspnoea as the outcome, which were not adjusted
for dyspnoea. The models for exacerbations were
additionally adjusted for the number of exacerbations in
the year before baseline. In the current analysis, we
calculated estimates for handgrip strength per 1 kg and
per 5 kg, and for the 1-min STS test per 1 repetition and
per 3 repetitions, which has recently been suggested as
the minimal important difference in COPD patients [8].
For mortality, we additionally calculated the area under
the curve (AUC) for commonly used predictors and
indices for mortality to compare their predictive dis-
crimination abilities. All analyses were conducted using
Stata version 14.1.
Results
We included all 409 patients for the handgrip strength
test and 371 patients for the 1-min STS test. Patients
were excluded if they did not conduct the 1-min STS
test at baseline (n = 5) or if they were not able to per-
form any repetitions in the 1-min STS test (n = 33).
Baseline mean (standard deviation (SD)) age was 67.3
(10.0) and 57% were male. Median (interquartile range)
FEV1 % of predicted at baseline was 58 (44, 68) and the
mean (SD) CRQ dyspnoea score was 4.7 (1.6). The mean
(SD) number of repetitions performed at baseline was
18.7 (8.3) and handgrip strength (kg) was 42.8 (10.1).
After 5 years, 77 (19%) of patients had died and exacer-
bation rate of 0.8 per person-year with a total of 1031
exacerbations.
The results of the 5-year analyses for each functional
exercise performance test and each outcome are
presented in Table 1. The 1-min STS test was statisti-
cally significantly associated with 5-year mortality per 3
repetitions (hazard ratio (HR): 0.81, 95% CI 0.65 to 0.86),
whereas the handgrip strength test was not statistically
significantly associated with mortality. Both the 1-min
STS test and handgrip strength test were moderately asso-
ciated with HRQoL, and neither test was statistically sig-
nificantly associated with exacerbations over 5 years. We
performed a sensitivity analysis restricted to severe exacer-
bations (n = 112) for the 1-min STS test and the incidence
rate ratio per 3 repetitions was 0.96 (95% CI 0.82 to 1.12).
AUC values for both tests are shown in Fig. 1. After
5 years, the 1-min STS test alone still had a larger AUC
for predicting mortality than other common individual
predictors (FEV1 % predicted, dyspnoea and body mass
index (BMI)), and was also the best performing modifiable
Table 1 Associations of the 1-min sit-to-stand (1-min STS) test and handgrip strength test with mortality, exacerbations and health
related quality of life (HRQoL)
Outcome 1-min STS test (n = 371) Handgrip strength test (n = 409)
Mortality Hazard ratio (95% CI) Hazard ratio (95% CI)
Per 1 more rep 0.93 (0.89 to 0.97) Per 1 more kg 0.97 (0.94 to 1.00)
Per 3 more reps 0.81 (0.65 to 0.86) Per 5 more kg 0.86 (0.73 to 1.01)
Exacerbations Incidence rate ratio (95% CI) Incidence rate ratio (95% CI)
Per 1 more rep 1.00 (0.99 to 1.02) Per 1 more kg 1.00 (0.98 to 1.02)
Per 3 more reps 1.01 (0.93 to 1.09) Per 5 more kg 1.00 (0.92 to 1.08)
HRQoL Effect (95% CI) Effect (95% CI)
CRQ dyspnoea
Per 1 more rep 0.05 (0.03 to 0.06) Per 1 more kg 0.02 (−0.00 to 0.03)
Per 3 more reps 0.15 (0.16 to 0.32) Per 5 more kg 0.08 (−0.00 to 0.15)
CRQ fatigue
Per 1 more rep 0.03 (0.02 to 0.05) Per 1 more kg 0.02 (0.01 to 0.04)
Per 3 more reps 0.10 (0.06 to 0.14) Per 5 more kg 0.12 (0.06 to 0.18)
CRQ emotional function
Per 1 more rep 0.01 (0.00 to 0.03) Per 1 more kg 0.01 (−0.00 to 0.02)
Per 3 more reps 0.04 (0.00 to 0.08) Per 5 more kg 0.03 (−0.02 to 0.09)
CRQ mastery
Per 1 more rep 0.02 (0.01 to 0.03) Per 1 more kg 0.01 (−0.00 to 0.02)
Per 3 more reps 0.05 (0.02 to 0.09) Per 5 more kg 0.04 (−0.01 to 0.10)
All models were adjusted for age, sex, FEV1 L, CRQ dyspnoea and LABA/ICS, except the model with CRQ dyspnoea as the outcome, which was not adjusted for
dyspnoea. The models for exacerbations were additionally adjusted for the number of exacerbations in the year before baseline. CRQ score is from 0–7,
0 = maximal impairment, 7 = no impairment.
Abbreviations: 1-min STS test 1-min sit-to-stand test, rep repetition, HRQoL health-related quality of life, CRQ Chronic Respiratory Questionnaire, CI confidence interval
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individual predictor. The 1-min STS test alone performed
better than the BODE index without an exercise compo-
nent (BOD) and increased the prognostic value when
added as the exercise component of BODE, but alone did
not perform better than the ADO index (Fig. 1).
Discussion
We found that over 5 years, the 1-min STS test was
strongly associated with mortality and moderately asso-
ciated with HRQoL. The handgrip strength test was not
statistically significantly associated with mortality or
HRQoL. Neither test was associated with exacerbations.
Overall, our results were comparable to the results of
our earlier study with a shorter, 2-year follow-up [2].
The strong association between 1-min STS test perform-
ance and mortality was only slightly reduced per 1 more
repetition (2-year HR 0.90, 95% CI 0.83 to 0.97 and
5-year HR 0.93, 95% CI 0.89 to 0.97). The associations
of the 1-min STS test with exacerbations, domains of the
CRQ and between the handgrip strength test and all out-
comes were also slightly reduced after 5 years compared
to 2 years. The present study suggests that the 1-min STS
test has long-term predictive validity for mortality and
that associations with outcomes only diminish slightly
over 5 years. However, the handgrip strength test loses
its statistical association with mortality after a longer
follow-up. This could be attributable to the different
requirements of the two tests; the 1-min STS test is
more physically demanding than the handgrip strength
test and is thus likely to capture a better approximation of
functional exercise performance.
The handgrip strength test has been proposed as a
simple test for predicting all-course mortality across
healthcare settings [9, 10]. Our results indicate that the
1-min STS test is an even more attractive test since it
was a much stronger predictor for mortality than the
hand-grip strength test (AUC for 1-min STS test 0.69
and handgrip-strength 0.55) and does not need ex-
pensive equipment, like a hand dynamometer. How-
ever, one limitation is that a small proportion of
patients may not be able to conduct the 1-min STS
test due to musculoskeletal or neurological limita-
tions, which can be a common limitation with many
functional exercise performance tests.
The lack of association seen between both tests and ex-
acerbations suggests that they do not predict the incidence
of exacerbations. In the sensitivity analysis restricted to
severe exacerbations no association with the 1-min STS
test was found, however the small number of severe exac-
erbations limits this analysis, and should be tested in
patients with more severe COPD to confirm these results.
Compared to the analysis at 2-years, we chose to include
slightly different confounders in order to ensure a more
comprehensive control of potential confounding. We
therefore performed a sensitivity analysis using the
original confounders to check how this change in method-
ology would impact the results. The results for all out-
comes at 5 years using the original 2-year confounders
were similar to the results with the updated confounders.
We believe that the results found in our study are general-
isable due to the large and diverse population in our
cohort, which reflects a representative sample of COPD
patients in primary care.
BMI
Handgrip strength
Dyspnoea (MRC)
FEV1 % predicted
BOD (without exercise capacity)
BODE (with handgrip strength)
STS test
BODE (with STS test)
Age
ADO
ADO + handgrip strength
ADO + STS test
0.5 0.6 0.7 0.8 0.9 1.0
Area under the curve
5 years
               2 years
Fig. 1 Areas under the curve and 95% confidence intervals for predictors of 5-year mortality compared to predictors of 2-year mortality in COPD
patients. ADO, age, dyspnoea, airflow obstruction; STS, sit-to-stand; BMI, body mass index; BODE, BMI, airflow obstruction, dyspnoea, exercise
capacity; MRC, Medical Research Council dyspnoea scale; FEV1, forced expiratory volume in 1 s
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Conclusion
In conclusion, the 1-min STS test as a measure of func-
tional exercise performance showed good long-term
predictive validity for the mortality and moderate pre-
dictive validity for HRQoL. This supports and extends
the existing evidence that the 1-min STS test could be
useful for assessing health status and long-term progno-
sis in COPD patients.
Abbreviations
1-min STS: 1-minute sit-to-stand; AUC: Area under the curve; BMI: Body mass
index; CI: Confidence interval; COPD: Chronic obstructive pulmonary disease;
CRQ: Chronic respiratory questionnaire; FEV1: Forced expiratory volume in 1 s;
HR: Hazard ratio; HRQoL: Health-related quality of life; SD: Standard deviation
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